Skip Nav Destination
A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcγRIIA and FcγIIIA genes
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation
Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register
Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
Issue Archive
June 1 2004
Table of Contents
INSIDE BLOOD
BLOOD WORK
REVIEW ARTICLES
REVIEW IN TRANSLATIONAL HEMATOLOGY
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcγRIIA and FcγIIIA genes
Clinical Trials & Observations
Sylvia Miescher,Martin O. Spycher,Hanspeter Amstutz,Masja de Haas,Marion Kleijer,Ulrich J. Kalus,Hartmut Radtke,Alphonse Hubsch,Irmgard Andresen,Roland M. Martin,Johann Bichler
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia
Clinical Trials & Observations
Mikkael A. Sekeres,Bercedis Peterson,Richard K. Dodge,Robert J. Mayer,Joseph O. Moore,Edward J. Lee,Jonathan Kolitz,Maria R. Baer,Charles A. Schiffer,Andrew J. Carroll,James W. Vardiman,Frederick R. Davey,Clara D. Bloomfield,Richard A. Larson,Richard M. Stone,for the Cancer and Leukemia Group B (CALGB)
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation
Clinical Trials & Observations
Nicolaus Kröger,Georgia Schilling,Hermann Einsele,Peter Liebisch,Avichai Shimoni,Arnon Nagler,Jose A. Perez-Simon,Jesus F. San Miguel,Michael Kiehl,Axel Fauser,Rainer Schwerdtfeger,Hannes Wandt,Herbert G. Sayer,Han Myint,Hans Klingemann,Tatjana Zabelina,Judith Dierlamm,Axel Hinke,Axel R. Zander
GENE THERAPY
Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus–based lentiviral vector system
Hideki Hanawa,Peiman Hematti,Keyvan Keyvanfar,Mark E. Metzger,Allen Krouse,Robert E. Donahue,Steve Kepes,John Gray,Cynthia E. Dunbar,Derek A. Persons,Arthur W. Nienhuis
HEMATOPOIESIS
Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register
Clinical Trials & Observations
Christine Bellanné-Chantelot,Séverine Clauin,Thierry Leblanc,Bruno Cassinat,Fernando Rodrigues-Lima,Sandrine Beaufils,Christelle Vaury,Mohamed Barkaoui,Odile Fenneteau,Micheline Maier-Redelsperger,Christine Chomienne,Jean Donadieu
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro
Robert Kleemann,Lars Verschuren,Bert-Jan de Rooij,Jan Lindeman,Moniek M. de Maat,Alexander J. Szalai,Hans M. G. Princen,Teake Kooistra
Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins
Clinical Trials & Observations
Brief Report
Jan-Dirk Studt,Johanna A. Kremer Hovinga,Radovan Radonic,Vladimir Gasparovic,Dragutin Ivanovic,Marijan Merkler,Urs Wirthmueller,Clemens Dahinden,Miha Furlan,Bernhard Lämmle
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
Clinical Trials & Observations
Brief Report
Jianmin Ding,Hirokazu Komatsu,Atsushi Wakita,Miyuki Kato-Uranishi,Masato Ito,Atsushi Satoh,Kazuya Tsuboi,Masakazu Nitta,Hiroshi Miyazaki,Shinsuke Iida,Ryuzo Ueda
IMMUNOBIOLOGY
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
Clinical Trials & Observations
Michael P. Crawford,Shirley X. Yan,Sterling B. Ortega,Riyaz S. Mehta,Rachel E. Hewitt,David A. Price,Peter Stastny,Daniel C. Douek,Richard A. Koup,Michael K. Racke,Nitin J. Karandikar
NEOPLASIA
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
Clinical Trials & Observations
Lisa M. Rimsza,Robin A. Roberts,Thomas P. Miller,Joseph M. Unger,Michael LeBlanc,Rita M. Braziel,Dennis D. Weisenberger,Wing C. Chan,H. Konrad Muller-Hermelink,Elaine S. Jaffe,Randy D. Gascoyne,Elias Campo,Deborah A. Fuchs,Catherine M. Spier,Richard I. Fisher,Jan Delabie,Andreas Rosenwald,Louis M. Staudt,Thomas M. Grogan
PHAGOCYTES
RED CELLS
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
Clinical Trials & Observations
Carmela Lanzara,Antonella Roetto,Filomena Daraio,Silvain Rivard,Romina Ficarella,Hervey Simard,Timothy M. Cox,Mario Cazzola,Alberto Piperno,Anne-Paule Gimenez-Roqueplo,Paola Grammatico,Stefano Volinia,Paolo Gasparini,Clara Camaschella
TRANSPLANTATION
T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation
Clinical Trials & Observations
Daniela Montagna,Franco Locatelli,Antonia Moretta,Daniela Lisini,Carlo Previderè,Pierangela Grignani,Piero DeStefano,Giovanna Giorgiani,Enrica Montini,Sara Pagani,Patrizia Comoli,Rita Maccario
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
Clinical Trials & Observations
Brief Report
Henk M. Lokhorst,Kalung Wu,Leo F. Verdonck,Laurens L. Laterveer,Niels W. C. J. van de Donk,Marinus H. J. van Oers,Jan J. Cornelissen,Anton V. Schattenberg
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals